RenovoRx RNXT
NASDAQ RNXT
$1.25 +0.04 (+3.75%)
As of: Oct 21, 2026 · 2:51 PM EDT

RenovoRx (RNXT) Other Non-Current Liabilities (2020)

Updated

RenovoRx's Other Non-Current Liabilities was $856,000 in Q4 2020.

Analysis

RenovoRx (RNXT) Other Non-Current Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.66 Bn 237.68 Bn 4.88 Bn
2 Abbott Laboratories 172.25 Bn 142.68 Bn 7.27 Bn
3 Danaher 163.69 Bn 147.49 Bn 3.61 Bn
4 Intuitive Surgical 152.41 Bn 131.83 Bn 1.96 Bn
5 Medtronic 119.51 Bn 84.76 Bn 6.34 Bn
6 Stryker 113.97 Bn 100.09 Bn 4.50 Bn
7 Boston Scientific 65.25 Bn 60.02 Bn 3.85 Bn
8 Becton Dickinson 53.52 Bn 50.67 Bn 2.32 Bn
9 Edwards Lifesciences 50.90 Bn 34.90 Bn 1.35 Bn
10 RenovoRx 58.89 Mn 19.92 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 856,000.00
API Access

RenovoRx Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=RNXT&period=max&api_key=YOUR_API_KEY